FindTrial
Sign In

DESIGNING AND DETERMINING THE EFFECTIVENESS OF INTERVENTIONS TO IMPROVE ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER

DESIGNING AND DETERMINING THE EFFICACY OF PSYCHO-SOCIAL INTERVENTIONS PACKAGE TO IMPROVE ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER - A MIXED METHOD STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045639
Enrollment
30
Registered
2022-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F25- Schizoaffective disorders Health Condition 2: F20- Schizophrenia

Interventions

Intervention1: Psychososcial Intervention Package: The intervention was designed based on a literature review and evidence from a qualitative study conducted to determine the common causes for non-adh

Sponsors

Dr Soumya Kumar Jha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting psychiatric patients between 18-65 years of age, with a clinical diagnosis of schizophrenia and schizoaffective disorder based on ICD 10 criteria and Family members/caregivers available for assessment.

Exclusion criteria

Exclusion criteria: Patientââ?¬•s not having access to a mobile phone Those admitted via magistrate order with no relatives. People with alcohol dependence syndrome with an AUDIT score of >20 Patient likely to move out of state or change treatment providers during the study period

Design outcomes

Primary

MeasureTime frame
Medication Adherence measured by Brief adherence rating scale and pill countsTimepoint: 1 month and 3 month—

Secondary

MeasureTime frame
2. Brief psychiatric rating scale (BPRS scale) - to assess the severity of symptoms in the person with schizophrenia and schizoaffective disorder 3. Drug Attitude Inventory (DAI - 10) - to assess patientââ?¬â?¢s perception and experiences of treatment 4. Brief Adherence Rating Scale (BARS)- to assess level of adherence 5. G12 item of PANSS scale ââ?¬â?? to assess the patients illness insight 6. WHODAS 2.0 short version will be used to assess quality of life Timepoint: 1 month and 3 months—

Countries

India

Contacts

Public ContactDr Soumya Kumar Jha

Institute of Psychiatry and Human Behaviour

wenona13@gmail.com08322458687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026